Folgen
Varun Vaidya
Varun Vaidya
Bestätigte E-Mail-Adresse bei utoledo.edu - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Gender differences in utilization of preventive care services in the United States
V Vaidya, G Partha, M Karmakar
Journal of women's health 21 (2), 140-145, 2012
4182012
Impact of cardiovascular complications among patients with Type 2 diabetes mellitus: a systematic review
V Vaidya, N Gangan, J Sheehan
Expert review of pharmacoeconomics & outcomes research 15 (3), 487-497, 2015
1452015
A mixed-methods analysis in assessing students’ professional development by applying an assessment for learning approach
MJ Peeters, VA Vaidya
American Journal of Pharmaceutical Education 80 (5), 77, 2016
382016
Utilization of preventive care services and their effect on cardiovascular outcomes in the United States
V Vaidya, G Partha, J Howe
Risk Management and Healthcare Policy, 1-7, 2011
352011
Clinical outcomes and cost-effectiveness of initial treatment strategies for nonembolic acute limb ischemia in real-life clinical settings
F Lurie, V Vaidya, AJ Comerota
Journal of Vascular Surgery 61 (1), 138-146, 2015
322015
Determining patient preferences of community pharmacy attributes: a systematic review
PM Patel, V Vaidya, F Osundina, DA Comoe
Journal of the American Pharmacists Association 60 (2), 397-404, 2020
252020
An international capstone experience for pharmacy students
DR Gourley, VA Vaidya, MA Hufstader, MD Ray, MA Chisholm-Burns
American Journal of Pharmaceutical Education 77 (3), 50, 2013
252013
Cost burden of the ‘presenteeism’ health outcome in a diverse nurse and pharmacist workforce: Practice models and health policy implications
CL Warren
The University of Tennessee Health Science Center, 2009
232009
Conjoint analysis of patient preferences on Medicare medication therapy management
SH Hong, J Liu, J Wang, L Brown, S White-Means
Journal of the American Pharmacists Association 51 (3), 378-387, 2011
222011
Utilization of smoking-cessation pharmacotherapy among chronic obstructive pulmonary disease (COPD) and lung cancer patients
V Vaidya, M Hufstader-Gabriel, N Gangan, S Shah, R Bechtol
Current medical research and opinion 30 (6), 1043-1050, 2014
202014
Emerging and encouraging trends in e-prescribing adoption among providers and pharmacies.
ME Gabriel, MF Furukawa, V Vaidya
The American Journal of Managed Care 19 (9), 760-764, 2013
202013
Cost-effectiveness of oral agents in relapsing-remitting multiple sclerosis compared to interferon-based therapy in Saudi Arabia
MF Alsaqa’aby, V Vaidya, N Khreis, T Al Khairallah, AH Al-Jedai
Annals of Saudi medicine 37 (6), 433-443, 2017
172017
Failure to refill essential prescription medications for asthma among pediatric Medicaid beneficiaries with persistent asthma
V Vaidya, R Gupte, R Balkrishnan
Patient preference and adherence, 21-26, 2013
152013
The impact of patient knowledge of patient-centered medication label content on quality of life among older adults
SH Hong, J Liu, S Tak, V Vaidya
Research in Social and Administrative pharmacy 9 (1), 37-48, 2013
152013
Pharmacists’ perceived barriers providing non-dispensing services to underserved populations
L Blazejewski, V Vaidya, S Pinto, C Gaither
Journal of community health 38, 812-822, 2013
142013
Cost-effectiveness analysis of initial treatment strategies for nonembolic acute limb ischemia using real-word data
V Vaidya, N Gangan, A Comerota, F Lurie
Annals of Vascular Surgery 39, 276-283, 2017
122017
Adoption of electronic prescribing for controlled substances among providers and pharmacies.
Y Yang, V Vaidya, TL Wilkins
The American Journal of Managed Care 20 (11 Spec No. 17), SP541-6, 2014
122014
Demographic disparities in patient-reported use of inhaled corticosteroids among patients with persistent asthma
V Vaidya, M Holiday-Goodman, S Pinto
Journal of asthma and allergy, 101-106, 2010
112010
Compromised Outcomes in Stage IV Non–Small-Cell Lung Cancer With Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of Real …
JA Scott, J Lennerz, ML Johnson, LN Gordan, RH Dumanois, L Quagliata, ...
JCO oncology practice 20 (1), 145-153, 2024
82024
Evaluation of outcomes in patients (pts) with stage 4 non-small cell lung cancer (NSCLC 4) harboring actionable oncogenic drivers (AOD) when treated prior to report of mutation …
RE Smith, ML Johnson, LN Gordan, M Xue, P Varughese, NA Dorrow, ...
Journal of Clinical Oncology 40 (16_suppl), 1530-1530, 2022
82022
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20